Drug survival and the associated predictors in South Korean patients with rheumatoid arthritis
receiving tacrolimus
Eun-Young Park, Seung-Geun Lee, Eun-Kyoung Park, Dong-Wan Koo, Ji-Heh Park, Geun-Tae Kim, Hee-Sang Tag, Hyun-Ok Kim, Young-Sun Suh
Korean J Intern Med. 2018;33(1):193-202. Published online 2016 Apr 6 DOI: https://doi.org/10.3904/kjim.2015.385
|
Citations to this article as recorded by
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia
Geoffrey Littlejohn, Joanna Leadbetter, Belinda E. Butcher, Marie Feletar, Catherine O’Sullivan, Tegan Smith, David Witcombe, Ho Yin Ng, Peter Youssef
Clinical Rheumatology.2024; 43(5): 1579. CrossRef Sustained Long-Term Retention Rates of Abatacept in Combination with Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis
Shuzo Sato, Haruki Matsumoto, Jumpei Temmoku, Yuya Fujita, Naoki Matsuoka, Makiko Yashiro-Furuya, Tomoyuki Asano, Eiji Suzuki, Hiroshi Watanabe, Takashi Kanno, Kiyoshi Migita
Medicina.2021; 57(9): 914. CrossRef Safety of Tacrolimus in Autoimmune Disease: Results From Post-marketing Surveillance in South Korea
Wan-Hee Yoo, Sang-Il Lee, Tae-Hwan Kim, Jung-Joon Sung, Seung Min Kim, Fan Hua, Budiwan Sumarsono, Sung Hwan Park
Journal of Rheumatic Diseases.2021; 28(4): 202. CrossRef Effects of overweight and underweight on the treatment outcomes of rheumatoid arthritis patients treated with biological drugs: A retrospective observational descriptive study
Toshinori Hirai, Ayako Funaki, Kumi Murakami, Kazuhiko Hanada, Toshimasa Itoh
Journal of Clinical Pharmacy and Therapeutics.2020; 45(4): 666. CrossRef The Impact of the Amendment of the Korean National Health Insurance Reimbursement Criteria for Anti-tumor Necrosis Factor-α Agents on Treatment Pattern, Clinical Response and Persistence in Patients With Rheumatoid Arthritis
Yunkyung Kim, Geun-Tae Kim, Young Sun Suh, Hyun-Ok Kim, Han-Na Lee, Seung-Geun Lee
Journal of Rheumatic Diseases.2020; 27(3): 159. CrossRef Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as predictors of 12-week treatment response and drug persistence of anti-tumor necrosis factor-α agents in patients with rheumatoid arthritis: a retrospective chart review analysis
Han-Na Lee, Yun-Kyung Kim, Geun-Tae Kim, Eunyoung Ahn, Min Wook So, Dong Hyun Sohn, Seung-Geun Lee
Rheumatology International.2019; 39(5): 859. CrossRef Manipulating the expression of SARP family regulator BulZ and its target gene product to increase tacrolimus production
Dongxu Ma, Cheng Wang, Hong Chen, Jianping Wen
Applied Microbiology and Biotechnology.2018; 102(11): 4887. CrossRef Efficacy and survival of golimumab with and without methotrexate in patients with psoriatic arthritis: A retrospective study from daily clinical practice
Kassem Sharif, Omer Gendelman, Pnina Langevitz, Tatiana Reitblat, Abdulla Watad, Yehuda Shoenfeld, Josef Azuri, Howard Amital, Nicola Luigi Bragazzi, Ora Shovman
Best Practice & Research Clinical Rheumatology.2018; 32(5): 692. CrossRef Neutropenia in the Elderly: A Rheumatology Perspective
Su-Ann Yeoh, Christine Fox, Richard Hull
Drugs & Aging.2016; 33(8): 585. CrossRef
|